Navigation Links
Osteotech Posts First Quarter Earnings Per Share of $.05 on Revenue Growth of 10%
Date:5/1/2008

EATONTOWN, N.J., May 1 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biological products for regenerative healing, announced today that revenue for the first quarter of 2008 increased 10% to $27.6 million from $25.2 million for the first quarter of 2007. Revenue from the Company's primary product lines, included in the DBM and Hybrid/Synthetic segments, was $17.6 million for the three months ended March 31, 2008, an increase of 12% over the prior year period. Revenue from our other product lines was $10.0 million and $9.5 million in the first quarter of 2008 and 2007, respectively.

Diluted earnings per share for the quarter ended March 31, 2008 was $.05 on net income of $.8 million compared to a net loss of $.6 million, or $.04 diluted loss per share, for the first quarter of 2007. The net loss in the first quarter of 2007 included the costs associated with the settlement of certain litigation and related legal fees of $1.1 million.

Gross margin improved to 52% in the first quarter compared to 49% in the first quarter of the prior year. Operating expenses increased 5% for the three months ended March 31, 2008 compared to the same period in 2007 due primarily to increased spending in research and development activities.

Sam Owusu-Akyaw, Osteotech's President and Chief Executive Officer, stated, "We continue to be pleased with the execution of our strategic initiatives. During the first quarter, we have continued to expand our product pipeline, penetrate the foot and ankle market with our Plexur P(TM) product and improve the effectiveness of our sales force. In the past two months, we have received FDA clearance for our Plexur P(TM) product for use in the spine and the Plexu
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
4. Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
5. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
6. Osteotech Receives FDA Clearance for Plexur M(TM) Biocomposite
7. Osteotech to Present at the Sidoti Conference in New York
8. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
9. Osteotech Announces First Quarter Earnings Release and Conference Call Schedule
10. Osteotech Renews Tissue Recovery Agreement with the Euro Atlantic Transplant Alliance
11. Osteotechs Plexur P(TM) Receives FDA Clearance as Bone Void Filler and Bone Graft Extender in Spine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... (PRWEB) May 20, 2013 Kitware, a ... visualization tool that enables the exploration of hospital ... created in response to the recent release of “Medicare ... the top 100 most-billed procedures from the Centers for ... costs for similar procedures at hospitals across the country ...
(Date:5/20/2013)... 2013 In Early 2013, Dr. ... biotoxin related illnesses , announced his vision for creating ... advance his protocol for treating Chronic Inflammatory Response Syndrome ... physician to achieve certification in the Shoemaker Protocol. ... practice the Shoemaker Protocol in other parts of the ...
(Date:5/20/2013)... The World Molecular Imaging Society (WMIS) Board ... as Executive Director. Baird will assume leadership of ... WMIS vision is to encompass and promote preclinical and ... diseases in the developed and developing world. The ... by integrating the Academy of Molecular Imaging and the ...
(Date:5/19/2013)... New York, NY (PRWEB) May 19, 2013 ... largest solar boat, today announced a new speed record ... Having left from Las Palmas, Spain, on April 25, ... across the Atlantic Ocean at the average speed of ... French West Indies on May 18, 2013. The first-of-its-kind ...
Breaking Biology Technology:Kitware Enables Interactive Exploration of CMS Medicare Data 2Dr. Ritchie Shoemaker Certifies Third Physician in His Treatment Protocol for Chronic Inflammatory Response Syndrome (CIRS) 2WMIS Appoints Lisa Baird as Next Executive Director 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 2MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 3MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 4MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 5MS Tûranor PlanetSolar Sets World Speed Record for Transatlantic Crossing by Solar Electric Vessel 6
... International, Inc. (OTC Bulletin Board: YGYB; "Yongye" or the ... products located in the People,s Republic of China, today ... retail stores in its sales network set a new ... in Qianjiang City in Hubei Province sold 15,310 bottles ...
... Sinovac Biotech Ltd. (NYSE Amex: SVA ), ... announced that it has filed its Annual Report on Form ... year ended December 31, 2008 on May 1, 2009. ... the Company,s website under the investor relations section at: ...
... BONITA SPRINGS, Fla., May 1 Tigris Pharmaceuticals, Inc., ... dosing has started in a Phase I clinical trial ... of geranylgeranyltransferase I (GGTase I) that induces apoptosis by ... I study is led by Dr. Peter O,Dwyer, Professor ...
Cached Biology Technology:Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 2Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day 3Sinovac Biotech Ltd. Files Annual Report on Form 20-F 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 2First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418 3
(Date:5/16/2013)... our pulses outside of the gym. But doctors use the ... , Zhenan Bao, a professor of chemical engineering at Stanford, ... and no wider than a postage stamp. The flexible skin-like ... sensitive enough to help doctors detect stiff arteries and cardiovascular ... continuously track heart health and provide doctors a safer method ...
(Date:5/16/2013)... , May 16, 2013 The ... Award on Tuesday to Germany,s ... biometric border control system. DERMALOG has been ... Best Practices Award in the category Global Biometrics and ... edge Biometric   Border Control System . One ...
(Date:5/15/2013)... "keystone" molecules that have powerful behavioral effects on ... in structuring ecosystems, according to a theory proposed ... The authors of the theory, Ryan P. Ferrer ... of the University of California at Los Angeles, ... plants that may be uncommon but exert a ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4Natural 'keystone molecules' punch over their weight in ecosystems 2
... claims advising breastfeeding moms that alcoholic beverages can improve ... Center report that even moderate doses of alcohol affect ... , "This information is important for women," comments lead ... is drinking alcohol just to improve the quality or ...
... for the first time that human eggs may develop ... from adult human ovaries. Oocytes derived from the culture ... suitable for fertilization and development into an embryo. These ... Biology and Endocrinology, offer important new strategies for use ...
... St. Louis have learned that a temporal "window of ... diabetic rats with embryonic pig tissues. , In those ... that they didn't have to give anti-rejection drugs to ... had expected rats that received no immune suppression would ...
Cached Biology News:Alcohol consumption disrupts breastfeeding hormones 2Alcohol consumption disrupts breastfeeding hormones 3Human Eggs Can Develop From Ovarian Surface Cells In Vitro 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
... Immunogen KLH-conjugated, synthetic ... 47-66 (PAEV-GPGAVGERTPRKKEPP) of human BRAF-HDAC ... (BHC110/LSD1). Quality Assurance ... Stability 2 years ...
Adducin beta (C-16)...
Geneticin Selective Antibiotic liquid...
...
Biology Products: